NeoStem fleshes out anti-ageing stem cell IP
This article was originally published in Clinica
Stem cell collection and banking services provider NeoStem has acquired exclusive worldwide rights to a stem cell technology for cosmetic skin rejuvenation procedures. The technology, which offers anti-ageing treatments using the patient's own stem cells, was developed by Dr Vincent Giampapa, a plastic reconstructive surgeon and a world-leading specialist in anti-ageing medicine. New York-based NeoStem said the licensing agreement will consolidate the company's position in the anti-ageing and regenerative medicine arena. The firm has a network of adult stem cell collection centres which stores the stem cells of customers for future use when the medical need arises.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.